Journal of the American Academy of Dermatology · Nov 15, 2026

Cutaneous Manifestations of the Menopausal Transition – Part 1: Epidemiology, Biology, Diagnosis and Workup

By Kim U, Gangal A, Li Y et al.

Menopause represents a physiologic transition characterized by the cessation of ovarian follicular estrogen synthesis and subsequent alterations in the hypothalamic-pituitary-ovarian axis, with broad systemic and cutaneous consequences. This review (Part 1) provides a comprehensive overview of the epidemiology, pathogenesis, diagnosis, and clinical evaluation of dermatologic manifestations associated with perimenopause and menopause. We summarize key hormonal changes, including declining estrogen and dynamic androgen shifts, and their downstream effects on skin structure and function through nuclear and membrane-associated estrogen receptor signaling pathways. The impact of estrogen deficiency across major cutaneous compartments—including the epidermis, dermis, hair follicle unit, sebaceous glands, vasculature, pigmentary system, and immune milieu—is examined, with emphasis on mechanisms underlying xerosis, impaired barrier function, dermal atrophy, alopecia, vasomotor instability, dyschromia, delayed wound healing, and vulvovaginal dermatoses. Dermatology-specific examination findings, limited utility of routine hormonal testing, and specific laboratory workup in patients with atypical or rapid-onset cutaneous hyperandrogenism are covered. This review equips clinicians with a mechanistic understanding of menopause-associated skin changes to support accurate diagnosis, appropriate workup, and informed management.

doi.org/10.1016/j.jaad.2026.11.026Open accessPubMed 43035217Mechanisms

AgingResearch.News